USANA Health Sciences (NYSE:USNA) Issues Quarterly Earnings Results

USANA Health Sciences (NYSE:USNA) released its quarterly earnings results on Tuesday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by ($0.22), FiscalAI reports. USANA Health Sciences had a negative net margin of 2.43% and a positive return on equity of 3.41%. The company had revenue of $205.89 million for the quarter, compared to the consensus estimate of $217.42 million.

USANA Health Sciences Trading Up 1.3%

Shares of NYSE USNA traded up $0.19 during midday trading on Tuesday, reaching $14.91. 290,270 shares of the stock were exchanged, compared to its average volume of 148,546. USANA Health Sciences has a 52-week low of $12.57 and a 52-week high of $23.59. The stock has a 50 day moving average price of $14.57 and a 200-day moving average price of $18.10. The company has a market capitalization of $275.46 million, a P/E ratio of -12.32, a P/E/G ratio of 1.60 and a beta of 0.68.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, September 21st. Zacks Research upgraded shares of USANA Health Sciences from a “strong sell” rating to a “hold” rating in a research report on Monday, October 5th. Finally, Wall Street Zen lowered shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce”.

About USANA Health Sciences

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.